PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

PANACEA LIFE SCIENCES HOLDINGS, INC.

Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024

$0.07+0.00 (+5.45%)

Close on Oct 19, 2026

Market cap: $1.15M
P/E (TTM): –
Dividend yield: –

PANACEA LIFE SCIENCES HOLDINGS, INC. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Cash & Equivalents	0.10	0.01	0.02	0.08	0.02	0.00	0.16	1.06	0	0.04	0.04
Short-Term Investments	0.01	1.11	3.79	2.85	–	–	–	–	–	0.00	–
Cash & Short-Term Investments	0.12	1.11	3.81	2.94	0.02	0.00	0.16	1.06	0	0.04	0.04
Receivables	0.26	0.21	0.24	0.15	0.06	0	–	–	–	0.00	–
Inventory	4.01	4.45	4.26	8.41	1.34	0	–	–	–	–	–
Prepaid Expenses & Other	0.26	0.11	0.28	0.03	0.25	0.01	0.01	0.02	0	0.00	–
Other Current Assets	–	–	–	0.01	–	–	–	–	–	–	–
Total Current Assets	4.66	6.38	9.10	12	2.43	0.01	0.17	1.08	0.08	0.06	–
Property, Plant & Equipment	6.45	7.68	8.84	14	0.48	0	–	0	0.00	0.02	–
Gross Property, Plant & Equipment	14	13	13	16	0.54	0	–	0	0.00	0.03	–
Accumulated Depreciation	-7.24	-5.52	-3.86	-2.50	-0.06	0	–	0	0.00	0.00	–
Operating Lease Right-of-Use Assets	3.86	3.24	3.60	3.94	0.39	0	–	–	–	–	–
Goodwill	3.01	2.19	2.19	2.19	–	–	–	–	–	–	–
Intangible Assets	3.01	2.19	0.06	0.12	2.15	0	–	0	0.00	0.00	–
Total Assets	18	19	24	31	8.02	0.01	0.17	2.13	0.08	0.08	–
Accounts Payable	4.63	2.67	1.69	1.77	1.44	0.92	0.74	0.57	0.08	0.03	–
Accrued Expenses	–	0.28	–	0.62	0.24	0.05	0.58	0.06	0.00	0.01	–
Current Portion of Long-Term Debt	–	–	–	0.70	0.19	–	–	–	–	–	–
Current Debt	–	–	–	0.70	0.19	0.49	0	–	–	–	–
Current Portion of Leases	2.91	2.09	1.62	1.16	0.17	0	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	0	0.22	0	–	–	–	–	–
Total Current Liabilities	19	15	10	18	3.81	3.34	2.39	0.62	0.18	0.04	–
Long-Term Debt	–	–	–	0.21	0	–	–	–	–	–	–
Long-Term Leases	3.25	2.99	3.35	3.69	0.22	0	–	–	–	–	–
Operating Lease Liabilities	3.97	3.35	3.69	4.60	0.39	0	–	–	–	–	–
Other Long-Term Liabilities	3.57	3.57	3.26	2.70	–	–	–	–	–	–	–
Total Liabilities	26	22	17	25	4.13	3.44	2.39	0.62	0.18	0.04	–
Total Debt	–	–	–	0.90	0.19	0.49	0	–	–	–	–
Preferred Stock	–	–	–	0	0	0	0	0	0	–	–
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	–
Additional Paid-In Capital	26	24	24	19	25	7.11	3.98	3.84	0.64	0.43	–
Retained Earnings	-34	-26	-17	-12	-21	-11	-6.20	-2.34	-0.74	-0.38	–
Comprehensive Income & Other	–	–	–	–	–	–	–	–	–	-0.01	–
Shareholders' Equity	-8.29	-2.14	7.10	6.71	12	-3.42	-2.22	1.50	-0.09	0.05	0.19
Noncontrolling Interest	–	–	–	-2.02	-0.54	0	–	–	–	–	–
Total Equity	-8.29	-2.14	7.10	6.71	12	-3.42	-2.22	1.50	-0.09	0.05	0.19
Total Liabilities & Equity	18	19	24	31	8.02	0.01	0.17	2.13	0.08	0.08	–
Shares Outstanding(shares)	18	15	14	17	1.56	0.22	0.16	0.15	0.00	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2024

Profitability, TTM

Gross margin: 56.5%
Operating margin: -192.2%
Net margin: -277.5%
Return on equity, FY2023: 153.6%

Financial strength

Current ratio: 0.23
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.5%

Valuation

P/E ratio: –
Price to sales: 0.42
Price to book: –
Dividend yield: –